PCI 3.06.26
Wallonia
Thermofisher: Thu 29 February 2024, 11:15

Current Edition

Current Features

Biomanufacturing

Form DAR control to Efficient Free Payload Removal

Continue reading

Upcoming Events

Bioprocessing summit
DDL 2026
ELRIG Drug Discovery USA
Biotechnology Show 13.02.26
PFS & Injectable drug devices west coast

Advertisement

Advertisement

A&M Stabtest April 26

Advertisement

CDD Vault – 18.03.2025

Advertisement

Biopharma Group – 19th March 2025

Advertisement

Micron View
Volume 7 Issue 4

Demonstrating Equivalence Between Recombinant Semaglutide APIs

This article presents a quality comparison between the recombinant origin Semaglutide drug substance made by Aurisco and the innovator’s injectable and oral Semaglut...
Continue Reading →
Demonstrating Equivalence Between Recombinant Semaglutide APIs
Application Notes

Demonstrating Equivalence Between Recombinant Semaglutide APIs

This article presents a quality comparison between the recombinant origin Semaglutide drug substance made by Aurisco and the innovator’s injectable and oral Semaglut...
Continue Reading →
Volume 7 Issue 4

Polypure Celebrates and Reflects on 25 Years in the Pharmaceutical Industry 

Polypure have been at the forefront of developments in the pharmaceutical industry for 25 years, being a driving force for high-quality PEG’s and PEG-derivatives. Ch...
Continue Reading →
Volume 7 Issue 4

Emerging Pharma vs. Big Pharma: Rethinking CRO Partnerships

In today’s competitive pharmaceutical landscape, outsourcing has become essential to the development and commercialisation of drugs. This is especially true for emer...
Continue Reading →
Volume 7 Issue 4

Breath Analysis and Cancer: The Future of Early Detection and Personalised Medicine 

VOCs and Breath  There are many challenges associated with cancer management, including delayed diagnosis, low efficacy of treatment, and heterogeneity of di...
Continue Reading →
Volume 7 Issue 4

In vitro Models Guiding Strategic Decision-making in Biotherapeutic Development

Scientific advancements and evolving regulatory requirements are continually reshaping the drug development process. Navigating the intricacies and financial challen...
Continue Reading →
Volume 7 Issue 4

Accelerating Drug Discovery: Integrating In Vivo and In Vitro Testing with C. elegans

The pharmaceutical industry is continually challenged by high attrition rates (> 90 %) as drug candidates progress from discovery, through clinical trials and to ...
Continue Reading →
Volume 7 Issue 4

Peptide Therapeutics: Unleashing the Power of Precision Medicine

In the dynamic world of drug discovery and development, where the quest for innovative and effective therapies is relentless, peptide therapeutics have emerged as a ...
Continue Reading →
Volume 7 Issue 4

Advancing Cancer Immunotherapy Research: The Role of Multiplex Immunoassays 

Immunotherapy has revolutionised the treatment of cancer. However, while it shows high efficacy against certain tumours, immunotherapy is not effective against all t...
Continue Reading →
Volume 7 Issue 4

Overcoming Oncology Drug Resistance: Models and Strategies

Cancer is inherently difficult to detect and treat. To add to this complication, some patients develop drug resistance to treatment, leading to tumour recurrence or ...
Continue Reading →

Advertisement

Richter: Wed 23 October 2024, 09:03

Advertisement

Aseptic Tech

Advertisement

Steribar – 12.05.2025

Advertisement

PharmExcel

Advertisement

Polypure hompage

Advertisement

Gen Xpro

Advertisement

Alphinity